검색
Lantheus Holdings Inc
LNTH관심 목록에 추가
99.640USD
-1.360-1.35%
종가 07-31 16:00（ET）시세는 15분 지연됩니다
6.48B시가총액
23.57P/E TTM
자세한 내용은 Lantheus Holdings Inc 회사
Lantheus Holdings, Inc. is a radiopharmaceutical-focused company engaged in delivering science to enable clinicians to find, fight and follow diseases to deliver patient outcomes. The Company classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Radiopharmaceutical Oncology diagnostics and therapeutics help healthcare professionals (HCPs) find, fight and follow cancer, with a focus on prostate cancer. Precision Diagnostic products assist HCPs to find and follow diseases, with a focus on cardiology. Strategic Partnerships focus on enabling precision medicine through the use of biomarker solutions, digital solutions, and radiotherapeutic platforms. Its commercial products include PYLARIFY, DEFINITY, TechneLite, Neuraceq, and others. Its clinical candidates include LNTH-2404, NAV-4694, and PNT2002, among others. The Neuraceq (florbetaben F18 injection) is an F-18 PET imaging agent for Alzheimer’s disease.
Lantheus Holdings Inc 정보
종목 코드 LNTH
회사 이름Lantheus Holdings Inc
상장일Jun 25, 2015
CEOMarkison (Brian A)
직원 수808
유형Ordinary Share
회계 연도 종료Jun 25
주소331 Treble Cove Road
도시NORTH BILLERICA
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호01862
전화19786718001
웹사이트https://www.lantheus.com/
종목 코드 LNTH
상장일Jun 25, 2015
CEOMarkison (Brian A)
Lantheus Holdings Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Ms. Mary Anne Heino
Ms. Mary Anne Heino
Executive Chairman of the Board, Interim Executive Officer
Executive Chairman of the Board, Interim Executive Officer
663.52K
-0.18%
Mr. Brian A. Markison
Mr. Brian A. Markison
Chief Executive Officer, Director
Chief Executive Officer, Director
180.68K
-28.64%
Dr. Jean-Claude Provost, M.D.
Dr. Jean-Claude Provost, M.D.
Chief Scientific Officer
Chief Scientific Officer
38.84K
-46.09%
Dr. James H. (Jim) Thrall
Dr. James H. (Jim) Thrall
Independent Director
Independent Director
37.34K
+11.08%
Dr. Gerard Ber, Ph.D.
Dr. Gerard Ber, Ph.D.
Independent Director
Independent Director
24.58K
+15.28%
Ms. Minnie Baylor-Henry, J.D.
Ms. Minnie Baylor-Henry, J.D.
Independent Director
Independent Director
11.50K
+35.98%
Dr. Phuong Khanh (P. K.) Morrow, M.D.
Dr. Phuong Khanh (P. K.) Morrow, M.D.
Independent Director
Independent Director
4.70K
+88.02%
Mr. Samuel R. (Sam) Leno
Mr. Samuel R. (Sam) Leno
Independent Director
Independent Director
--
--
Ms. Julie H. Mchugh
Ms. Julie H. Mchugh
Lead Independent Director
Lead Independent Director
--
--
Mr. Gary John Pruden
Mr. Gary John Pruden
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Ms. Mary Anne Heino
Ms. Mary Anne Heino
Executive Chairman of the Board, Interim Executive Officer
Executive Chairman of the Board, Interim Executive Officer
663.52K
-0.18%
Mr. Brian A. Markison
Mr. Brian A. Markison
Chief Executive Officer, Director
Chief Executive Officer, Director
180.68K
-28.64%
Dr. Jean-Claude Provost, M.D.
Dr. Jean-Claude Provost, M.D.
Chief Scientific Officer
Chief Scientific Officer
38.84K
-46.09%
Dr. James H. (Jim) Thrall
Dr. James H. (Jim) Thrall
Independent Director
Independent Director
37.34K
+11.08%
Dr. Gerard Ber, Ph.D.
Dr. Gerard Ber, Ph.D.
Independent Director
Independent Director
24.58K
+15.28%
Ms. Minnie Baylor-Henry, J.D.
Ms. Minnie Baylor-Henry, J.D.
Independent Director
Independent Director
11.50K
+35.98%
자주 묻는 질문
Lantheus Holdings Inc의 상위 5대 주주는 누구인가요?
Lantheus Holdings Inc의 상위 5대 주주는 다음과 같습니다: Ms. Mary Anne Heino
Lantheus Holdings Inc(LNTH)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Lantheus Holdings Inc의 주식을 보유한 기관은 총 1043곳이며, 이들이 보유한 주식의 총 가치는 약 77.80M로 전체 발행 주식의 119.49%를 차지합니다. 이는 2025Q4 대비 -5936003.00 증가한 수치입니다.